In the preceding three months, 4 analysts have released ratings for Quantum-Si QSI, presenting a wide array of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 0 | 1 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 1 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $4.0, a high estimate of $5.50, and a low estimate of $1.00. Observing a 6.67% increase, the current average has risen from the previous average price target of $3.75.
Understanding Analyst Ratings: A Comprehensive Breakdown
The analysis of recent analyst actions sheds light on the perception of Quantum-Si by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Swayampakula Ramakanth | HC Wainwright & Co. | Maintains | Buy | $5.50 | $5.50 |
| Swayampakula Ramakanth | HC Wainwright & Co. | Raises | Buy | $5.50 | $4.00 |
| Kyle Mikson | Canaccord Genuity | Lowers | Hold | $1.00 | $1.50 |
| Swayampakula Ramakanth | HC Wainwright & Co. | Maintains | Buy | $4.00 | $4.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Quantum-Si. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Quantum-Si compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Quantum-Si's stock. This comparison reveals trends in analysts' expectations over time.
For valuable insights into Quantum-Si's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Quantum-Si analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
All You Need to Know About Quantum-Si
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.
Unraveling the Financial Story of Quantum-Si
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Positive Revenue Trend: Examining Quantum-Si's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 252.91% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Quantum-Si's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -3216.39%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Quantum-Si's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -11.41%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Quantum-Si's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -10.26%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Quantum-Si's debt-to-equity ratio is below the industry average at 0.07, reflecting a lower dependency on debt financing and a more conservative financial approach.
How Are Analyst Ratings Determined?
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
